Search - tctmd.com

Displaying 181 - 200 of 231

Sort: Relevancy | Date

Presentation Fellows 2014

LAA Closure for Nonvalvular Atrial Fibrillation

Presenter: William Gray

April 14, 2014

Presentation TCT 2013

LAA Exclusion for Patients with Atrial Fibrillation: Appropriate Indications, Concerns, and Unanswered Questions

Presenter: Reda Ibrahim

October 31, 2013

News Conference News TCT 2013

Debate Leaves Little Doubt of LAA Closure Efficacy in the Prevention of Stroke in AF Patients

October 30, 2013

Presentation TCT 2013

A Cost Benefit Analysis of Left Atrial Appendage Closure Versus Warfarin for Stroke Prevention in Atrial Fibrillation

Presenter: Vivek Y. Reddy

October 29, 2013

Presentation TCT 2013

Long term follow up of 134 patients with non valvular atrial fibrillation and contraindications to oral anticoagulation therapy, treated with the Ampatzer Cardiac Plug Device for LAA

Presenter: Miroslava Stolcova

October 29, 2013

Presentation TCT 2013

Case Presentation: LAA Exclusion in a Patient With Atrial Fibrillation

Presenter: Evgeny Merkulov

October 28, 2013

Presentation TCT 2013

Stroke, Bleeding and Risk Scores in Atrial Fibrillation (with and without Anticoagulation)

Presenter: Stefan Bertog

October 27, 2013

Presentation TCT 2013

Multicenter Experience with the ACP for Stroke Prevention in Atrial Fibrillation

Presenter: Apostolos Tzikas

October 27, 2013

Presentation TCT 2013

LAA Closure in Valvular Atrial Fibrillation (and TAVR Patients): Rationale and Results

Presenter: Samir Kapadia

October 27, 2013

News Conference News ESC 2013

Pooled Trial, Registry Data Support Watchman for Stroke Prevention in A-fib

Yael L. Maxwell

September 02, 2013

News Daily News

心房纤维颤动患者封堵装置血栓形成风险因素已被确认

Yael L. Maxwell

June 28, 2013

News Daily News

Risk Factors for Thrombus Formation on Cardiac Plug in A-fib Patients Identified

Yael L. Maxwell

June 28, 2013

Presentation TVT 2013

EP Perspective: Where Will A-fib Ablation Take Us in the Next Five Years?

Presenter: Darryl Wells

June 15, 2013

Presentation TVT 2013

Defining Nonvalvular A-fib: Not So Simple

Presenter: Michael Ezekowitz

June 15, 2013

Presentation TVT 2013

"New" Anticoagulation Options for A-fib: Beyond Warfarin

Presenter: Michael Ezekowitz

June 15, 2013

News Daily News

Oclusión de LAA más rentable que la warfarina y que el dabigatran para pacientes con fibrilación auricular

Yael L. Maxwell

June 07, 2013

News Daily News

LAA Occlusion More Cost-effective Than Both Warfarin and Dabigatran for A-fib Patients

Yael L. Maxwell

June 07, 2013

Presentation

Percutaneous LAA Closure with the Amplatzer Cardiac Plug in Patients with Nonvalvular A-fib and Contraindications for Anticoagulation Therapy

Presenter: M. Urena

May 28, 2013

News Daily News

Cardiac Plug Shows High Success, Low Complication Rate for LAA Closure

L.A. McKeown

May 28, 2013

News Daily News

PROTECT AF: 4-Year Results Show Superiority of Watchman Over Warfarin for A-fib

Yael L. Maxwell

May 17, 2013

Advertisement

LAA Closure for Nonvalvular Atrial Fibrillation

LAA Exclusion for Patients with Atrial Fibrillation: Appropriate Indications, Concerns, and Unanswered Questions

Debate Leaves Little Doubt of LAA Closure Efficacy in the Prevention of Stroke in AF Patients

A Cost Benefit Analysis of Left Atrial Appendage Closure Versus Warfarin for Stroke Prevention in Atrial Fibrillation

Long term follow up of 134 patients with non valvular atrial fibrillation and contraindications to oral anticoagulation therapy, treated with the Ampatzer Cardiac Plug Device for LAA

Case Presentation: LAA Exclusion in a Patient With Atrial Fibrillation

Stroke, Bleeding and Risk Scores in Atrial Fibrillation (with and without Anticoagulation)

Multicenter Experience with the ACP for Stroke Prevention in Atrial Fibrillation

LAA Closure in Valvular Atrial Fibrillation (and TAVR Patients): Rationale and Results

Pooled Trial, Registry Data Support Watchman for Stroke Prevention in A-fib

心房纤维颤动患者封堵装置血栓形成风险因素已被确认

Risk Factors for Thrombus Formation on Cardiac Plug in A-fib Patients Identified

EP Perspective: Where Will A-fib Ablation Take Us in the Next Five Years?

Defining Nonvalvular A-fib: Not So Simple

"New" Anticoagulation Options for A-fib: Beyond Warfarin

Oclusión de LAA más rentable que la warfarina y que el dabigatran para pacientes con fibrilación auricular

LAA Occlusion More Cost-effective Than Both Warfarin and Dabigatran for A-fib Patients

Percutaneous LAA Closure with the Amplatzer Cardiac Plug in Patients with Nonvalvular A-fib and Contraindications for Anticoagulation Therapy

Cardiac Plug Shows High Success, Low Complication Rate for LAA Closure

PROTECT AF: 4-Year Results Show Superiority of Watchman Over Warfarin for A-fib

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content